FDA Ends Emergency Use for COVID Medical Devices
Published Date: 7/2/2026
Notice
Summary
The U.S. Department of Health and Human Services is ending the emergency use authorizations for certain COVID-19 medical devices, including tests and masks, on December 26, 2026. This change affects manufacturers, healthcare providers, and anyone using these devices, signaling a return to normal rules and regulations. No emergency use means these products will now follow regular approval processes, with no extra emergency funding involved.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 2 costs, 1 mixed.
Manufacturers Must Seek Regular Approval
FDA and HHS are encouraging manufacturers of EUA-authorized COVID-19 tests, personal respiratory protective devices, and other medical devices to obtain authorization through traditional premarket/marketing pathways and to begin transition planning. FDA issued final guidance in March 2023 and HHS is providing 180 days advance notice before termination, with the declarations ending on December 26, 2026.
EUA Termination for COVID-19 Devices
The Department of Health and Human Services is terminating three emergency-use declarations for (1) in vitro diagnostic COVID-19 tests, (2) personal respiratory protective devices (masks), and (3) certain medical devices on December 26, 2026. This affects manufacturers, healthcare providers, and anyone using those devices because they will no longer be covered by the emergency authorizations.
No Emergency Funding; Product Disposition Rules
HHS states there will be no extra emergency funding tied to these EUAs and that, if an EUA ceases to be effective, HHS/FDA will consult with manufacturers about appropriate disposition or return of unapproved products. The notice also functions as the required 180-day advance notice before the December 26, 2026 termination.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22812, Medicare and Medicaid Programs; Cutting Administrative Requirements for Excellence in Patient Care
CMS is proposing to cut outdated and tricky rules in Medicare and Medicaid to help doctors and nurses spend more time caring for patients instead of paperwork. These changes aim to save money, boost flexibility, and make healthcare better and easier to manage. Comments on this plan are open until January 11, 2027, so everyone affected can share their thoughts!
2026-22792, Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
Starting in 2029, Medicare will negotiate drug prices to help lower costs for people using Medicare Part D. This new rule, effective December 5, 2026, sets clear policies to make prescription drugs more affordable and fair. If you or a loved one uses Medicare for prescriptions, expect some savings and changes in how drug prices are set.
2026-22750, Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies
Starting in 2027, Medicare is updating how it pays home health agencies, including new payment rates and rules to make care better and fairer. Home health providers, equipment suppliers, and Medicare enrollees will see changes in payment methods, quality reporting, and equipment rules, with some new deadlines and expanded benefits. These updates aim to improve care quality while keeping payments clear and fair.
2026-22743, Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Starting January 1, 2027, Medicare and Medicaid are updating how doctors and clinics get paid to better match real medical work and new laws. This includes new rules for drug price rebates, sharing savings programs, and payment updates for rural clinics and ambulance services. These changes affect doctors, patients, and healthcare providers, aiming to keep care fair, affordable, and up-to-date.
2026-22739, Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots
Starting in 2027, Medicare is updating how hospitals and surgery centers get paid for outpatient care and surgeries. These changes affect hospitals, surgery centers, and patients by adjusting payment rates and improving quality reporting. Plus, CMS is asking for ideas to make hospital price info clearer and easier to compare, while also handling rules about emergency care and teaching hospital closures.
2026-22381, Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage
This new rule updates how Organ Procurement Organizations (OPOs) operate to help get more life-saving organs to people who need transplants. It changes some definitions, competition rules, and appeal processes to make OPOs work better and be held accountable. These changes start January 4, 2027, and aim to save more lives without adding extra costs.
Previous / Next Documents
Previous: 2026-13369, Submission for Office of Management and Budget Review; Office of Refugee Resettlement Annual Survey of Refugees
The Office of Refugee Resettlement wants to keep running its Annual Survey of Refugees through 2027 without changing the questions right now. This survey helps the government understand and support refugee families who arrived in the last five years. They’re asking for public feedback by August 3, 2026, and plan to improve the survey later based on new online testing.
Next: 2026-13374, Termination of Declaration Authorizing Emergency Use of Drug and Biological Products During the COVID-19 Pandemic
The U.S. Department of Health and Human Services is ending the special emergency rules that allowed quick use of COVID-19 drugs and vaccines. This change affects companies, healthcare workers, and patients who relied on these emergency approvals. The emergency use authorization will officially stop on June 29, 2027, giving everyone time to adjust without sudden disruptions or extra costs.